Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

NCT00878930 · clinicaltrials.gov ↗
COMPLETED
Status
500
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca